Organon & Co. (OGN) PT Raised to $24 at Piper Sandler
Tweet
Share
E-mailGet Alerts OGN Hot Sheet
Price: $13.40 +0.15%
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Organon & Co. (NYSE: OGN) to $24.00 (from $22.00) while maintaining a Overweight rating.
The analyst commented, "Our price target of $24 (up from $22) is based on an EV/EBITDA multiple of 7x (unchanged) our 2024E EBITDA estimate of $2,020M (from $2,064M previously). We are no longer using a discount period for our PT calculation as it is based on 2024 EBITDA (that is the key driver of our revised PT). "
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- BTIG Upgrades Medtronic, Inc. (MDT) to Buy
- Bernstein SocGen Group Starts Cipher Mining (CIFR) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
